Background
Worldwide, there are about 36.7 million people living with HIV, 2.1 million newly infected people with HIV, and 1.1 million deaths from HIV until the end of 2015. [1] [2] [3] [4] Sub-Saharan Africa is the most affected region, with 25.6 (23.1-28.5) million people living with HIV. 1 According to the World Health Organization (WHO) 2016 report, approximately 18.2 million people are under antiretroviral therapy (ART) follow-up globally. 4 Based on the national HIV AIDS Prevention and Control Office 2016 report of Ethiopia, 740,000 persons are living in Ethiopia with HIV, 84,000 (12%) are chil-submit your manuscript | www.dovepress.com
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Belay et al dren, with an overall prevalence rate of 1.2%, of which only 377,000 (50.9%) are under ART. 5 With free HIV testing and ART service there should be no HIV-related death; however, death of HIV patients in the world, especially in developing countries such as Ethiopia, is still being reported. 2, 4, [6] [7] [8] [9] [10] [11] One of the contributors for these deaths could be late diagnosis of HIV. [12] [13] [14] [15] [16] As early diagnosis is key for tracing HIV-positive people, this leads to initiation of ART earlier, and hence might significantly reduce the rate of HIV-related mortality. 4, 9, 13, [17] [18] [19] Currently, Ethiopia has changed the eligibility criteria of HIV-positive people for ART utilization. The country is implementing a guideline that every HIV-positive individual should get ART treatment whether he/she is diagnosed late (<350 cells/mm 3 cluster of differentiation 4 [CD4] cell count) or early in the disease process (≥350 cells/mm 3 CD4 cell count). 1, 7, 10, 20 Drug and testing availability in Ethiopia are expanding to primary health care facilities and through campaign services. However, there are hardly any studies that confirm if improved availability and accessibility of HIV services has positively affected people to be diagnosed earlier. 4, 6, 16, 21 Therefore, this study was aimed at assessing the relationship between late diagnosis of HIV and HIVrelated mortality.
Methods
Study design and setting
A retrospective cohort study was conducted in general hospitals of Central Zone Tigray, Ethiopia by reviewing patients' records from ART clinics between 2010 and 2015. Tigray regional state, located 1,024 km to the north of Addis Ababa, the capital city of Ethiopia, and Central Zone are located 240 km from Mekelle, the capital city of Tigray regional state. The zone has 12 districts called "weredas" and a total of eight hospitals. It has one referral, three general, and four primary hospitals. In this study, record reviews from the three general hospitals are included for analysis.
Sampling and study population
The source population included all HIV patients, aged ≥15 years, who had received no ART and those who presented for ART follow-up at the three general hospitals from July 2010 to June 2015. Sampled HIV patients who fulfilled the inclusion criteria were included for analysis. The sample size was calculated using stpower Cox in Stata version 12.0 software package (StataCorp LP, College Station, TX, USA). Estimation was based on assumptions with power of 80%, α (type I) error of 5%, 8.85% proportion of death among exposed (CD4 cell count <350 cells/mm 3 ), hazard ratio (HR) of 2.15 with 0.5 standard deviation (SD), and lost to follow-up rate of 5%. 22 Based on the above assumptions, the total sample size included for analysis had 638 patients with exposed to nonexposed ratio of 1:1. Patients were proportionally allocated to each hospital according to the number of enrolled HIV patients during the study period. Thus, 310, 218, and 110 HIV patients were included for analysis from Aksum St Mary, Adwa, and Tembien Abi-Adi General Hospitals, respectively (Tigray Health Bureau, unpublished data, 2014). Patients with an incomplete baseline CD4 cell count were excluded. Then, systematic random sampling method was used to sample individuals from the eligible patients in the records.
Variables and measurement
The outcome variable is a binary outcome, categorized as censored (alive HIV patients) and time to death event (deceased HIV patients). Censored patients are those who were alive until the most recent follow-up period and deceased patients are those who died at any time during the 5 years' retrospective follow-up period.
The main exposure variable is period of diagnosis of HIV, categorized as early diagnosis versus late diagnosis of HIV. Exposed patients are those with late diagnosis of HIV (who present with CD4 cell count <350 cells/mm 3 ), whereas nonexposed patients are those with early diagnosis of HIV (who present with CD4 cell count ≥350 cells/mm 3 ).
Other independent variables (possible covariates)
Sociodemographic variables such as age, sex, marital status, level of education, religion, occupation, residence, past medical history of any opportunistic infections (OIs), clinical factors such as weight, functional status, WHO clinical staging, and hemoglobin level were included as possible covariates for analysis.
Data collection tool and quality assurance mechanisms
A data collecting checklist was prepared based on routine data registration protocol using standardized HIV care and followup forms employed by the pre-ART and ART clinics in health facilities of Ethiopia. Data were extracted from records by three ART staff nurses working in the three selected hospitals using the prepared data collecting checklist after receiving 2 days training on how to extract data from the records. 
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Effect of late HIV diagnosis on HIV-related mortality among adults as baseline data. To assure quality of data extraction, a pretest was conducted in 5% (32 patients) of the sampled individuals from Suhul Hospital, Shire, Northwest Tigray, Ethiopia.
Data management and analysis procedures
Data were double entered into EpiData version 3.1 software (Odense, Denmark) and transferred into Stata version 12 software for analysis. Prior to analysis, data were cleaned for completeness using frequency and cross-tabulation. Recoding, categorization, and sorting of data to facilitate analysis were done using the Stata software. Person-days of follow-up were calculated by subtracting date of HIV-related death or last date of follow-up for censoring from the date of HIV confirmation of patients. Both bivariable and multivariable Cox proportional hazard regression models were used to verify the effect of late HIV diagnosis on HIV-related death of patients and other independent predictors of mortality at 5% level of significance (α). Only variables which were significant in the bivariable analysis were entered into the final model. The assumptions, multicollinearity, normality, and proportionality of hazards over time were checked. The P-value of the proportionality of hazards over time in global test, using Schoenfeld residuals, was 0.49. Even though the P-value was significant in the bivariable analysis, baseline WHO clinical staging was not included in the final model because it demonstrated collinearity with the main exposure variable (baseline CD4 cell count). Variables which were significant (P-value <0.05) in the multivariate analysis were considered independent predictors of HIV-related mortality.
Ethical consideration
This study obtained ethical approval from the Institutional Review Board of Aksum University College of Health Sciences. In addition, the medical directors' offices of each hospital granted permission to use the patients' data for this study. All data had no personal identifiers and were kept confidential and therefore did not require informed consent.
Results
Characteristics of cohorts
A total of 638 HIV patients from the record reviews were analyzed having a mean age of 34. Late HIV diagnosis as a predictor of HIVrelated mortality
In all, 638 HIV patients, contributing 2,105.6 person-years of follow-up, were followed for 5 years retrospectively. Of these, 
Discussion
The overall incidence of HIV-related death among patients on ART follow-up in general hospitals of Central Zone of Tigray, Ethiopia over 5 years in this study was 7.5% (with 95% CI 5.5%-9.6%). Late diagnosis of HIV was a predictor of HIV-related death. Patients with late diagnosis of HIV (CD4 cell count ≤ 350 cells/mm3) showed three-fold higher rates of death from HIV compared to patients with early diagnosis (CD4 cell count >350 cells/mm 3 ). Other studies also supported the finding of the current study that baseline CD4 cell count is a significant laboratory predictor of HIVrelated death, in a sense that patients with higher baseline CD4 cell counts are associated with longer survival. 
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To effectively treat HIV/AIDS and have positive outcomes for individual patients, HIV should be diagnosed as early as possible, when the individual has a CD4 cell count above 350 cells/mm. 16, 21 It is therefore very important to start ART at higher CD4 counts which inversely affects transmission and mortality of HIV/AIDS.
Rural patients with HIV had higher hazard of death compared to urban patients. Being unemployed by occupation was also another significant predictor of HIV-related mortality among patients with HIV. Other studies have also revealed rural residence and unemployment as demographic predictors of survival among patients with HIV. 26, 27 Baseline blood hemoglobin level and baseline functional status of patients were also predictors of survival among patients with HIV in this study. Patients with baseline hemoglobin level <11 mg/dL were more likely to die of HIV/AIDS than their counterparts. Patients who were bedridden and ambulatory in baseline functional status were at a higher risk of death from HIV than patients who had working baseline functional status. This is due to the fact that immunecompromised individuals are at higher risk of poor prognosis from any disease than immune-competent individuals. This finding is most likely due to the fact that patients who are bedridden are more likely exposed to different infections and have the possibility to have several OIs which lower immunity and thereby lead to early death. 28 Patients with low baseline hemoglobin level were at a higher risk of death from HIV than their counterparts. This is because anemic patients, as a result of super-infections to HIV, require more time to recover from their illness or become totally unable for good prognosis of recovery from their illness though they are under ARV drugs. Finally, this poor prognosis of the illness leads to death.
The main limitation of this study is that the data we used are secondary data and cannot incorporate other possible predictors of HIV-related mortality such as drug resistance, substance abuse, unspecified OIs, and other possible confounders.
Conclusion and recommendation
Late diagnosis of HIV has increased mortality. Rural residence, unemployment, bedridden and ambulatory patients (as compared to those who are working), and baseline hemoglobin level <11 mg/dL were also independent predictors of HIV-related mortality. The study showed a significant positive relationship between late HIV diagnosis and mortality; therefore, to control death from HIV/AIDS, governmental policy makers and nongovernmental organizations should have a strong focus on identifying HIV-infected individuals as early as possible. Patients with poor baseline clinical and laboratory conditions should also be given more emphasis as their disease progression is more rapid and leads to earlier death.
